N-[2-(4-MORPHOLINO)ETHYL]-N'-AMINOGUANIDINE (MEAG) INHIBITS AGE FORMATION INVITRO AND DIABETIC CHANGES IN STZ-DIABETIC RATS WITHOUT INHIBITING DIAMINE OXIDASE (DAO) OR NITRIC-OXIDE SYNTHASE (NOS)
Vm. Mallon et al., N-[2-(4-MORPHOLINO)ETHYL]-N'-AMINOGUANIDINE (MEAG) INHIBITS AGE FORMATION INVITRO AND DIABETIC CHANGES IN STZ-DIABETIC RATS WITHOUT INHIBITING DIAMINE OXIDASE (DAO) OR NITRIC-OXIDE SYNTHASE (NOS), Diabetes, 42, 1993, pp. 106-106
Citations number
NO
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal","Public, Environmental & Occupation Heath